182 related articles for article (PubMed ID: 14697910)
1. Persistency with latanoprost or timolol in primary open-angle glaucoma suspects.
Schwartz GF; Reardon G; Mozaffari E
Am J Ophthalmol; 2004 Jan; 137(1 Suppl):S13-6. PubMed ID: 14697910
[TBL] [Abstract][Full Text] [Related]
2. Patient persistency with topical ocular hypotensive therapy in a managed care population.
Reardon G; Schwartz GF; Mozaffari E
Am J Ophthalmol; 2004 Jan; 137(1 Suppl):S3-12. PubMed ID: 14697909
[TBL] [Abstract][Full Text] [Related]
3. Patient persistency with ocular prostaglandin therapy: a population-based, retrospective study.
Reardon G; Schwartz GF; Mozaffari E
Clin Ther; 2003 Apr; 25(4):1172-85. PubMed ID: 12809964
[TBL] [Abstract][Full Text] [Related]
4. Patient persistency with pharmacotherapy in the management of glaucoma.
Reardon G; Schwartz GF; Mozaffari E
Eur J Ophthalmol; 2003 Jul; 13 Suppl 4():S44-52. PubMed ID: 12948052
[TBL] [Abstract][Full Text] [Related]
5. Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension.
Netland PA; Landry T; Sullivan EK; Andrew R; Silver L; Weiner A; Mallick S; Dickerson J; Bergamini MV; Robertson SM; Davis AA;
Am J Ophthalmol; 2001 Oct; 132(4):472-84. PubMed ID: 11589866
[TBL] [Abstract][Full Text] [Related]
6. Persistency and treatment failure in newly diagnosed open angle glaucoma patients in the United Kingdom.
Zhou Z; Althin R; Sforzolini BS; Dhawan R
Br J Ophthalmol; 2004 Nov; 88(11):1391-4. PubMed ID: 15489479
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of single glaucoma medication in combined latanoprost and timolol XE therapy in patients with open-angle glaucoma and ocular hypertension: a discontinuation study.
Kobayashi H
J Ocul Pharmacol Ther; 2012 Aug; 28(4):387-91. PubMed ID: 22335426
[TBL] [Abstract][Full Text] [Related]
8. Changes in intraocular pressure following a switch from latanoprost monotherapy to latanoprost/timolol fixed combination therapy in patients with primary open-angle glaucoma or ocular hypertension: results from a clinical practice database.
Lazaridou MN; Montgomery DM; Ho WO; Jaberoo D
Curr Med Res Opin; 2008 Oct; 24(10):2725-8. PubMed ID: 18713491
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of single glaucoma drug in combined timolol XE, latanoprost and brinzolamide therapy: a discontinuation study.
Kobayashi H
J Ocul Pharmacol Ther; 2012 Jun; 28(3):245-50. PubMed ID: 22283238
[TBL] [Abstract][Full Text] [Related]
10. The influence of diclofenac ophthalmic solution on the intraocular pressure-lowering effect of topical 0.5% timolol and 0.005% latanoprost in primary open-angle glaucoma patients.
Costagliola C; Parmeggiani F; Antinozzi PP; Caccavale A; Cotticelli L; Sebastiani A
Exp Eye Res; 2005 Nov; 81(5):610-5. PubMed ID: 15949795
[TBL] [Abstract][Full Text] [Related]
11. Twenty-four-hour diurnal curve comparison of commercially available latanoprost 0.005% versus the timolol and dorzolamide fixed combination.
Konstas AG; Papapanos P; Tersis I; Houliara D; Stewart WC
Ophthalmology; 2003 Jul; 110(7):1357-60. PubMed ID: 12867391
[TBL] [Abstract][Full Text] [Related]
12. Ocular hypotensive effects and safety over 3 months of switching from an unfixed combination to latanoprost 0.005%/timolol maleate 0.5% fixed combination.
Inoue K; Okayama R; Higa R; Sawada H; Wakakura M; Tomita G
J Ocul Pharmacol Ther; 2011 Dec; 27(6):581-7. PubMed ID: 22011049
[TBL] [Abstract][Full Text] [Related]
13. Circadian intraocular pressure control with dorzolamide versus timolol maleate add-on treatments in primary open-angle glaucoma patients using latanoprost.
Tamer C; Oksüz H
Ophthalmic Res; 2007; 39(1):24-31. PubMed ID: 17164574
[TBL] [Abstract][Full Text] [Related]
14. A comparison of the effects of dorzolamide/timolol fixed combination versus latanoprost on intraocular pressure and pulsatile ocular blood flow in primary open-angle glaucoma patients.
Janulevicienë I; Harris A; Kagemann L; Siesky B; McCranor L
Acta Ophthalmol Scand; 2004 Dec; 82(6):730-7. PubMed ID: 15606472
[TBL] [Abstract][Full Text] [Related]
15. Short-term effect of latanoprost and timolol eye drops on tear fluid and the ocular surface in patients with primary open-angle glaucoma and ocular hypertension.
Thygesen J; Aaen K; Theodorsen F; Kessing SV; Prause JU
Acta Ophthalmol Scand; 2000 Feb; 78(1):37-44. PubMed ID: 10726786
[TBL] [Abstract][Full Text] [Related]
16. Discontinuation rates of topical glaucoma medications in a managed care population.
Shaya FT; Mullins CD; Wong W; Cho J
Am J Manag Care; 2002 Aug; 8(10 Suppl):S271-7. PubMed ID: 12188170
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and side effects of latanoprost monotherapy compared to adding dorzolamide to timolol in patients with glaucoma and ocular hypertension--a three-month randomised study. Spanish Latanoprost Study Group.
García Sanchez J
Eur J Ophthalmol; 2000; 10(3):198-204. PubMed ID: 11071026
[TBL] [Abstract][Full Text] [Related]
18. Intraocular pressure-lowering effects of latanoprost monotherapy versus latanoprost or pilocarpine in combination with timolol: a randomized, observer-masked multicenter study in patients with open-angle glaucoma. Italian Latanoprost Study Group.
Bucci MG
J Glaucoma; 1999 Feb; 8(1):24-30. PubMed ID: 10084271
[TBL] [Abstract][Full Text] [Related]
19. Fixed combination of latanoprost and timolol vs individual components for primary open-angle glaucoma or ocular hypertension: a randomized, double-masked study.
Higginbotham EJ; Olander KW; Kim EE; Grunden JW; Kwok KK; Tressler CS;
Arch Ophthalmol; 2010 Feb; 128(2):165-72. PubMed ID: 20142538
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness and safety of dorzolamide-timolol alone or combined with latanoprost in open-angle glaucoma or ocular hypertension.
Lesk MR; Koulis T; Sampalis F; Sampalis JS; Bastien NR
Ann Pharmacother; 2008 Apr; 42(4):498-504. PubMed ID: 18364402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
